Enamines
eMolecules 354824-17-2 | 5-(Aminomethyl)-N,N-dimethylpyridin-2-amine | Combi-Blocks | MFCD08272104 | 151.213 | C8H13N3 | 98.000 | CN(C)c1ccc(CN)cn1 | 1g | 117575175
5-(Aminomethyl)-N,N-dimethylpyridin-2-amine | Combi-Blocks | 354824-17-2 | MFCD08272104 | 151.213 | C8H13N3 | 98.000 | CN(C)c1ccc(CN)cn1 | 1g | 117575175
eMolecules 14205-39-1 | Methyl 3-aminocrotonate | Chem-Impex115.132 | C5H9NO2 | 98.000 | COC(=O)C=C(C)N | 25g | 386901549
Methyl 3-aminocrotonate | Chem-Impex | 14205-39-1115.132 | C5H9NO2 | 98.000 | COC(=O)C=C(C)N | 25g | 386901549
eMolecules 1117-71-1 | METHYL 4-BROMOBUT-2-ENOATE | AstaTech | MFCD00000246 | 179.013 | C5H7BrO2 | 80.000 | COC(=O)\C=C\CBr | 25g | 457903317
METHYL 4-BROMOBUT-2-ENOATE | AstaTech | 1117-71-1 | MFCD00000246 | 179.013 | C5H7BrO2 | 80.000 | COC(=O)\C=C\CBr | 25g | 457903317
Medchemexpress LLC (S)-Nimodipine | 77940-93-3 | 418.44 | 5 MG
(S)-Nimodipine ((S)-BAY-e 9736) is an enantiomer of Nimodipine. Nimodipine (BAY-e 9736) is an orally active, well-tolerated, and light-sensitive dihydropyridine calcium antagonist. It can be used for the research of cerebrovascular disorders.
- Target: Calcium channel
- Pathway: Membrane transporter/ion channel; neuronal signaling
- Storage (powder): -20°C for 3 years, 4°C for 2 years
- Storage (in solvent): -80°C for 6 months, -20°C for 1 month
- Solubility in vitro: DMSO: 100 mg/mL (238.98 mM; requires ultrasonic)
eMolecules 39741-62-3 | tert-butyl (2S)-2,5-diamino-5-oxopentanoate hydrochloride | Synthonix - Stock | MFCD00039081 | 238.710 | C9H19ClN2O3 | 95.000 | Cl.CC(C)(C)OC(=O)[C@@H](N)CCC(N)=O | 25g | 495874754
tert-butyl (2S)-2,5-diamino-5-oxopentanoate hydrochloride | Synthonix - Stock | 39741-62-3 | MFCD00039081 | 238.710 | C9H19ClN2O3 | 95.000 | Cl.CC(C)(C)OC(=O)[C@@H](N)CCC(N)=O | 25g | 495874754
Selleck Chemical LLC Nimodipine S1747-1g
Nimodipine (BAY E 9736) is a dihydropyridine calcium channel blocker and an autophagy inhibitor used in the treatment of high blood pressure
Apexbio Technology LLC Amlodipine 88150-42-9 1g
Amlodipine (CAS 88150-42-9) is a dihydropyridine-based small molecule that functions as a long-acting calcium channel blocker It selectively inhibits L-type calcium channels on vascular smooth muscle and cardiac myocytes thereby reducing intracellular calcium influx This action leads to vasodilation and decreased vascular resistance Amlodipine is widely utilized in biomedical research to investigate calcium signaling pathways vascular tone modulation and cardiovascular pharmacology Its mechanistic profile also makes it a reference compound in studies evaluating novel antihypertensive or vasodilatory agents
Medchemexpress LLC (R)-Nimodipine | 77940-92-2 | 99.9% | 25 MG
(R)-Nimodipine is an orally active, blood-brain barrier-permeable L-type calcium channel blocker with an IC50 of 5 nM. It inhibits corticosterone release by blocking calcium channels on the hypothalamic-pituitary-adrenal axis, reversing immobilization stress-induced memory impairment and behavioral abnormalities. This compound is widely used in studies related to aneurysmal subarachnoid hemorrhage, cerebral ischemia, epilepsy, age-related degenerative neurological diseases, and alcohol intoxication.
- Orally active and blood-brain barrier-permeable
- L-type calcium channel blocker
- Inhibits corticosterone release
- Reverses immobilization stress-induced memory impairment
- Used in research for neurological and cerebrovascular diseases
- Inhibits slow inactivating Ca2+ currents in vitro
- Soluble in DMSO for experimental use
- Provided with in vivo protocols for various formulations
Medchemexpress LLC CDK2-IN-4 | 1316652-41-1 | 99.3% | 326.37 g/mol | C16H14N4O2S | 5 MG
NCC-149 is a selective histone deacetylase 8 (HDAC8) inhibitor used in cell biology research, including studies of neural differentiation. The product is provided with supporting documentation for purity, handling, and storage, and is available both as a solid and as a DMSO solution.
- Selective HDAC8 inhibitor for neural differentiation studies.
- Documented purity approximately 99.3% based on certificate of analysis.
- Available as a solid and as a 10 mM solution in DMSO.
- Datasheet, certificate of analysis, and safety data sheet provided for quality and safety information.
- Storage recommendations included for powdered material and solutions.
Medchemexpress LLC PF-562271 besylate | 939791-38-5 | MFCD14105612 | 99.2% | 665.66 g/mol | C27H26F3N7O6S2 | 1 ML
PF-562271 besylate is a potent, ATP-competitive, reversible inhibitor of focal adhesion kinase (FAK) and Pyk2 used in biochemical, cell-based, and in vivo research. It is supplied as a 10 mM solution in DMSO and exhibits low-nanomolar activity against FAK and nanomolar activity against Pyk2.
- Potent inhibition of FAK and Pyk2 (FAK IC50 = 1.5 nM; Pyk2 IC50 = 13 nM).
- Supplied as a ready-to-use 10 mM solution in DMSO for in vitro assays.
- High reported purity suitable for research use (99.17%).
- Demonstrated antiproliferative activity across multiple cancer cell lines.
- Validated pharmacological effects in vivo, including inhibition of FAK phosphorylation.
Med Vet International AmLodipine Besylate Tablets (Norvsac), 10mg, 1000ct
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Amlodipine Besylate Tablets (norvsac), 10mg, 1000ct